Where does Abbvie Stemcentrx LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbvie Stemcentrx LLC ranks #7,969 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abbvie Stemcentrx LLC hold?

Abbvie Stemcentrx LLC holds 40 US utility patents granted between 2016 and 2021, spanning 8 technology areas.

What is Abbvie Stemcentrx LLC's Innovation Score?

Abbvie Stemcentrx LLC has an Innovation Score of 37.8 out of 100 (top 42% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abbvie Stemcentrx LLC focus on?

Abbvie Stemcentrx LLC's top technology area is C07K (Peptides) with 38 patents, ranking #252 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Abbvie Stemcentrx LLC's patent grant rate increasing or decreasing?

Abbvie Stemcentrx LLC's recent grant velocity is -86% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abbvie Stemcentrx LLC's patents?

Abbvie Stemcentrx LLC's patents average 26.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abbvie Stemcentrx LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abbvie Stemcentrx LLC

USPTO PatentsView assignee record - 40 granted patents across 8 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbvie ranks #7,969 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 8 technology areas.

#7,969
of 49,997 US assignees by volume: Top 42%
by Innovation Score (37.8/100): 26.4
avg claims per patent: -86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7969 · US Corporation #7,969 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 40 grants
UPPER-Q #7,969/49,997
PHOTO-FINISH 2266170 Ontario
CPC-NARROW C07K · 8 areas
INNOV-THIN 37.8/100
CLAIMS-DENSE 26.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 2266170 Ontario Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abbvie’s 37.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (34%) Velocity 0.0 pts (0%) Breadth 10.0 pts (26%) Claim depth 15.0 pts (40%)

Qualcomm Incorporated · highest

85
Abbvie Stemcentrx · this assignee

38
FedEx Supply Chain… · near

38
Machine Zone · near

38
Powertech Industrial · near

38
Tomey · near

38
3D Lighting… · lowest

7

What this shows Abbvie's Innovation Score is 37.8/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abbvie?

Each dot is one of Abbvie’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbvie’s own 26.4 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abbvie vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abbvie's grants concentrate

Abbvie Stemcentrx LLC is a focused PatentsView assignee: 8 CPC subclasses with 95% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (19 grants) versus a trough of 2 in 2020. By volume, Abbvie sits between Worthington Industries, Inc. and AR & NS Investment, LLC.

Worthington Indus…

41
Zhejiang Chint El…

41
Zafgen

41
2266170 Ontario

40
Alios Biopharma

40
Amcor Rigid Packa…

40
Anchor Hocking

40
AR & NS Investment

40
Abbvie Stemcentrx ◀

40

What this shows Abbvie holds 40 patents at rank #7,969, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbvie

By rank, the assignees closest to #7,969 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Abbvie's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abbvie, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Abbvie ranks #252 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Machine Zone Inc. 38 Powertech Industrial Co., Ltd. 38 Tomey Corporation 38 FedEx Supply Chain Logistics & Electronics, Inc. 38

Abbvie's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 42% higher than 58% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Abbvie Stemcentrx LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	7.5%
2017	9	22.5%
2018	19	47.5%
2019	4	10.0%
2020	2	5.0%
2021	3	7.5%

Which technologies does Abbvie Stemcentrx LLC patent most?

C07K - Peptides 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 38

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 36

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 22

C07D - Heterocyclic Compounds 15

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C12Y - Enzymes 4

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abbvie Stemcentrx LLC's patent record in context - here's where to go next.

Abbvie Stemcentrx LLC's lead technology class is C07K (Peptides), 95% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #7,969 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbvie Stemcentrx LLC against Worthington Industries, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.